Home / Leflunomide / United States
US ATC L04AK01 · updated 2 Nov 2026
Leflunomide shortage in United States
Is there a Leflunomide shortage in United States?
Yes. As of 2 Nov 2026, 3 Leflunomide products are reported short in United States, the first since 8 Jun 2026. No return date has been given. Main reason: not stated.
Also short in Canada, Italy. All countries.
Affected products in United States
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Arava, Tablet, 10 mg (NDC 0088-2160-30) discontinuation | Sanofi-Aventis U.S. LLC | 8 Jun 2026 | not given | Not stated |
| US | Arava, Tablet, 100 mg (NDC 0088-2162-33) discontinuation | Sanofi-Aventis U.S. LLC | 8 Jun 2026 | not given | Not stated |
| US | Arava, Tablet, 20 mg (NDC 0088-2161-30) discontinuation | Sanofi-Aventis U.S. LLC | 8 Jun 2026 | not given | Not stated |
Source
U.S. Food and Drug Administration (FDA), Drug Shortages via openFDA. Official list. Shortages the FDA lists as current, plus products to be discontinued; one row per package (NDC).